COVID-19 Rheumatic Disease News Roundup

September 01, 2020

Rheumatic disease patients have a unique set of concerns when it comes to COVID-19. To date, the evidence suggests, that for patients who have few, if any comorbidities, an infection may not be any worse than those in the general population. Learn more in this news roundup and slideshow.

Study Hints at COVID-19 Risk for Rheumatic Disease Patients

August 27, 2020

Researchers in China write in the current issue of The Lancet Rheumatology that patients with autoimmune rheumatic disease might be more susceptible to COVID-19 infections than the general population.

These Two Tests May Determine COVID-19 Severity

August 27, 2020

A proportion of patients with COVID-19 are more prone to developing COVID-19-associated hyperinflammation regardless of age and comorbidity status, finds an observational study published on Friday in The Lancet Rheumatology.

Long-Term Use of Hydroxychloroquine May Increase Mortality Risk

August 25, 2020

A retrospective study published in The Lancet Rheumatology shows that the long-term use of hydroxychloroquine to treat rheumatoid arthritis patients may increase the risk of cardiovascular mortality.